Cannabix Technologies Appoints VP of Technology Development
February 11, 2020
Vancouver, British Columbia, February 11, 2020 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace is pleased to report that Dr. Moe Paknahad has joined the Company as VP of Technology Development. Dr. Paknahad will help direct product development of Cannabix’s THC breathalyzer devices. Dr. Paknahad is an Electrical Engineer who has spent last 10 years on research and development and product development in biomedical and environmental monitoring devices with skills in prototyping, piloting and commercialization.
Dr. Paknahad received his PhD in electrical engineering at the University of British Columbia (UBC) an completed his post-doctorate at University of Toronto. He is a specialist in the areas of microfluidics, machine olfaction, sensors, organ-on-chip and lab-on-chip technologies. More recently he served as a product development specialist at CellScale Biomaterials and VitroFlo based in Ontario developing organ-on-chip in-vitro devices for drug screening purposes. In addition, he served as a technical lead and co-founder of early stage company developing energy harvesting technology. Dr. Paknahad played a significant role at UBC helping invent microfluidic gas analysis technology which is used for different applications ranging from human breath analysis to gas leakage detection in natural gas infrastructures.
Dr. Raj Attariwala stated, “Dr. Paknahad has deep knowledge of sensor technologies, pilot prototype production as well as commercialization and will be a great addition to our technical team for both microfluidic technologies and FAIMS.”
The Company has granted 200,000 stock options exercisable at $.80 for period of 2 years.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.